ALDX SG&A Expense Growth
Aldeyra Therapeutics Inc · SG&A Expense Growth
ALDX SG&A Expense Growth
Latest reported-19.26%period ending
ALDX FY SG&A Growth (YoY) (0.00% → -19.26%)
Latest values, visible window
High-resolution chart · PNG
ALDX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -19.2553% | |
| -10.8218% | |
| -13.2598% | |
| 36.2573% | |
| 12.9944% | |
| -17.849% | |
| 23.0761% | |
| 59.6508% | |
| 12.0652% | |
| 25.0283% | |
| 23.9124% | |
| 66.8852% | |
| 231.038% | |
| -13.3075% | |
| 0% |